Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2019 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2019 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination

  • Authors:
    • Ayman Mohamed
    • Ghada Al-Kafaji
    • Amal Almahroos
    • Zahra Almosawi
    • Hawra Alalwan
    • Reem Abdulla
    • Fajer Alammadi
    • Ahmed Almubarak
    • Ahmed Al-Mahrezi
    • Amer Kamal
  • View Affiliations / Copyright

    Affiliations: Department of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain, Department of Molecular Medicine and Al-Jawhara Centre for Molecular Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama Block 329, Kingdom of Bahrain
  • Pages: 566-572
    |
    Published online on: June 10, 2019
       https://doi.org/10.3892/etm.2019.7654
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Impairment in cognition and motor activity are commonly encountered in patients affected by multiple sclerosis (MS), and depression is believed to be a contributing factor. The aim of the present study was to investigate the impact of induced depression on a cuprizone mouse model of demyelination and the effectiveness of enhanced environment (EE) as a method of intervention. C57BL/6 male mice were divided into five groups: Cuprizone only (Cup‑O), cuprizone undergoing depression (Cup-Dep), cuprizone housed in EE (Cup-EE), cuprizone housed in EE and undergoing depression (Cup-ED) and the control (n=9-10 per group). Depression was induced by repeated open-space forced swim. Neurobehavioral tests were conducted following a 6-week period of 0.2% cuprizone-enriched diet. The Cup-EE group performed significantly better in terms of cognition and motor functions, when compared with the Cup-O group, as evidenced by the Morris water maze (MWM; P<0.001) and rotarod performance test (P<0.05) results. Conversely, the Cup-Dep group exhibited a significant decline in performance in the MWM (P<0.001) and rotarod performance test (P<0.05), when compared with the Cup-O group. The Cup-ED group had comparable results to those of the Cup-O group, indicating a reversal of the induced depression effects. Open field test results failed to show an anxiety-like behavior in the cuprizone mouse model. It was therefore concluded that EE can improve MS-associated cognitive and motor deficits. Insights gained from these results facilitate the exploration of non-medical modes of intervention as an emerging adjuvant therapy in MS.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Beer S, Khan F and Kesselring J: Rehabilitation interventions in multiple sclerosis: An overview. J Neurol. 259:1994–2008. 2012. View Article : Google Scholar : PubMed/NCBI

2 

Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hämäläinen P, Hartung HP, Krupp L, Penner IK, et al: Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 18:891–898. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Amato MP, Zipoli V and Portaccio E: Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies. J Neurol Sci. 245:41–46. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Cioncoloni D, Innocenti I, Bartalini S, Santamecchi E, Rossi S, Rossi A and Ulivelli M: Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants. J Neurol Sci. 345:213–219. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Salter A, Thomas N, Tyry T, Cutter G and Marrie RA: Employment and absenteeism in working-age persons with multiple sclerosis. J Med Econ. 20:493–502. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Raimo S, Trojano L, Pappacena S, Alaia R, Spitaleri D, Grossi D and Santangelo G: Neuropsychological correlates of theory of mind deficits in patients with multiple sclerosis. Neuropsychology. 31:811–821. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Gay MC, Bungener C, Thomas S, Vrignaud P, Thomas PW, Baker R, Montel S, Heinzlef O, Papeix C, Assouad R and Montreuil M: Anxiety, emotional processing and depression in people with multiple sclerosis. BMC Neurol. 17:432017. View Article : Google Scholar : PubMed/NCBI

8 

Rahn K, Slusher B and Kaplin A: Cognitive impairment in multiple sclerosis: A forgotten disability remembered. Cerebrum. 2012:142012.PubMed/NCBI

9 

Siegert RJ and Abernethy DA: Depression in multiple sclerosis: A review. J Neurol Neurosurg Psychiatry. 76:469–475. 2005. View Article : Google Scholar : PubMed/NCBI

10 

Kazlauckas V, Pagnussat N, Mioranzza S, Kalinine E, Nunes F, Pettenuzzo L, Souza DO, Portela LV, Porciúncula LO and Lara DR: Enriched environment effects on behavior, memory and BDNF in low and high exploratory mice. Physiol Behav. 102:475–480. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Zhao YY, Shi XY, Qiu X, Lu W, Yang S, Li C, Chen L, Zhang L, Cheng GH and Tang Y: Enriched environment increases the myelinated nerve fibers of aged rat corpus callosum. Anat Rec (Hoboken). 295:999–1005. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Cao W, Duan J, Wang X, Zhong X, Hu Z, Huang F, Wang H, Zhang J, Li F, Zhang J, et al: Early enriched environment induces an increased conversion of proBDNF to BDNF in the adult rat's hippocampus. Behav Brain Res. 265:76–83. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Wood NI, Carta V, Milde S, Skillings EA, McAllister CJ, Ang YL, Duguid A, Wijesuriya N, Afzal SM, Fernandes JX, et al: Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of huntington's disease. PLoS One. 5:e90772010. View Article : Google Scholar : PubMed/NCBI

14 

Magalon K, Cantarella C, Monti G, Cayre M and Durbec P: Enriched environment promotes adult neural progenitor cell mobilization in mouse demyelination models. Eur J Neurosci. 25:761–771. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Kipp M, Clarner T, Dang J, Copray S and Beyer C: The cuprizone animal model: New insights into an old story. Acta Neuropathol. 118:723–736. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Torkildsen O, Brunborg LA, Myhr KM and Bø L: The cuprizone model for demyelination. Acta Neurol Scand Suppl. 188:72–76. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Kipp M, Nyamoya S, Hochstrasser T and Amor S: Multiple sclerosis animal models: A clinical and histopathological perspective. Brain Pathol. 27:123–137. 2017. View Article : Google Scholar : PubMed/NCBI

18 

Komoly S: Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected]. Ideggyogy Sz. 58:40–43. 2005.PubMed/NCBI

19 

Stidworthy MF, Genoud S, Suter U, Mantei N and Franklin RJ: Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol. 13:329–339. 2003. View Article : Google Scholar : PubMed/NCBI

20 

Matsushima GK and Morell P: The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11:107–116. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Morell P, Barrett CV, Mason JL, Toews AD, Hostettler JD, Knapp GW and Matsushima GK: Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci. 12:220–227. 1998. View Article : Google Scholar : PubMed/NCBI

22 

Skripuletz T, Gudi V, Hackstette D and Stangel M: De-and remyelination in the CNS white and grey matter induced by cuprizone: The old, the new, and the unexpected. Histol Histopathol. 26:1585–1597. 2011.PubMed/NCBI

23 

Dumitrascu OM, Mott KR and Ghiasi H: A comparative study of experimental mouse models of central nervous system demyelination. Gene Ther. 21:599–608. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Ingram G, Loveless S, Howell OW, Hakobyan S, Dancey B, Harris CL, Robertson NP, Neal JW and Morgan BP: Complement activation in multiple sclerosis plaques: An immunohistochemical analysis. Acta Neuropathol Commun. 2:532014. View Article : Google Scholar : PubMed/NCBI

25 

Artola A, von Frijtag JC, Fermont PC, Gispen WH, Schrama LH, Kamal A and Spruijt BM: Long-lasting modulation of the induction of LTD and LTP in rat hippocampal CA1 by behavioural stress and environmental enrichment. Eur J Neurosci. 23:261–272. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Yankelevitch-Yahav R, Franko M, Huly A and Doron R: The forced swim test as a model of depressive-like behavior. J Vis Exp. 2–Mar;2015.doi: 10.3791/52587. View Article : Google Scholar

27 

Castagné V, Moser P and Porsolt RD: Behavioral assessment of antidepressant activity in rodents. Methods of behavior analysis in neuroscience. 2nd. Boca Raton (FL): CRCPress/Taylor & Francis; 2009

28 

Porsolt RD, Le Pichon M and Jalfre M: Depression: A new animal model sensitive to antidepressant treatments. Nature. 266:730–732. 1977. View Article : Google Scholar : PubMed/NCBI

29 

Porsolt RD, Bertin A and Jalfre M: ‘Behavioural despair’ in rats and mice: Strain differences and the effects of imipramine. Eur J Pharmacol. 51:291–294. 1978. View Article : Google Scholar : PubMed/NCBI

30 

Stone EA, Lin Y and Quartermain D: Evaluation of the repeated open-space swim model of depression in the mouse. Pharmacol Biochem Behav. 91:190–195. 2008. View Article : Google Scholar : PubMed/NCBI

31 

D'Hooge R and De Deyn PP: Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev. 36:60–90. 2001. View Article : Google Scholar : PubMed/NCBI

32 

Bohlen M, Cameron A, Metten P, Crabbe JC and Wahlsten D: Calibration of rotational acceleration for the rotarod test of rodent motor coordination. J Neurosci Methods. 178:10–14. 2009. View Article : Google Scholar : PubMed/NCBI

33 

Sachs HH, Bercury KK, Popescu DC, Narayanan SP and Macklin WB: A new model of cuprizone-mediated demyelination/remyelination. ASN Neuro. 6(pii): 17590914145519552014.PubMed/NCBI

34 

Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J and Uitdehaag BMJ: Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. J Neurol Sci. 372:331–341. 2017. View Article : Google Scholar : PubMed/NCBI

35 

Bilgi E, Özdemir HH, Bingol A and Bulut S: Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression. Arq Neuropsiquiatr. 73:90–95. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Alwis DS and Rajan R: Environmental enrichment and the sensory brain: The role of enrichment in remediating brain injury. Front Syst Neurosci. 8:1562014. View Article : Google Scholar : PubMed/NCBI

37 

Serra-de-Oliveira N, Boilesen SN, Prado de França Carvalho C, LsSueur-Maluf L, Zollner Rde L, Spadari RC, Medalha CC and Monteiro de Castro G: Behavioural changes observed in demyelination model shares similarities with white matter abnormalities in humans. Behav Brain Res. 287:265–275. 2015. View Article : Google Scholar : PubMed/NCBI

38 

Acharjee S, Nayani N, Tsutsui M, Hill MN, Ousman SS and Pitman QJ: Altered cognitive-emotional behavior in early experimental autoimmune encephalitis-Cytokine and hormonal correlates. Brain Behav Immun. 33:164–172. 2013. View Article : Google Scholar : PubMed/NCBI

39 

Rodrigues DH, Vilela Mde C, Lacerda-Queiroz N, Miranda AS, Sousa LF, Reis HJ and Teixeira AL: Behavioral investigation of mice with experimental autoimmune encephalomyelitis. Arq Neuropsiquiatr. 69:938–942. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Spires TL and Hannan AJ: Nature, nurture and neurology: Gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw. FEBS J. 272:2347–2361. 2005. View Article : Google Scholar : PubMed/NCBI

41 

Von Frijtag JC, Kamal A, Reijmers LG, Schrama LH, van den Bos R and Spruijt BM: Chronic imipramine treatment partially reverses the long-term changes of hippocampal synaptic plasticity in socially stressed rats. Neurosci Lett. 309:153–156. 2001. View Article : Google Scholar : PubMed/NCBI

42 

Bliss TV and Cooke SF: Long-term potentiation and long-term depression: A clinical perspective. Clinics (Sao Paulo). 66 (Suppl 1):S3–S17. 2011. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Mohamed A, Al-Kafaji G, Almahroos A, Almosawi Z, Alalwan H, Abdulla R, Alammadi F, Almubarak A, Al-Mahrezi A, Kamal A, Kamal A, et al: Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination. Exp Ther Med 18: 566-572, 2019.
APA
Mohamed, A., Al-Kafaji, G., Almahroos, A., Almosawi, Z., Alalwan, H., Abdulla, R. ... Kamal, A. (2019). Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination. Experimental and Therapeutic Medicine, 18, 566-572. https://doi.org/10.3892/etm.2019.7654
MLA
Mohamed, A., Al-Kafaji, G., Almahroos, A., Almosawi, Z., Alalwan, H., Abdulla, R., Alammadi, F., Almubarak, A., Al-Mahrezi, A., Kamal, A."Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination". Experimental and Therapeutic Medicine 18.1 (2019): 566-572.
Chicago
Mohamed, A., Al-Kafaji, G., Almahroos, A., Almosawi, Z., Alalwan, H., Abdulla, R., Alammadi, F., Almubarak, A., Al-Mahrezi, A., Kamal, A."Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination". Experimental and Therapeutic Medicine 18, no. 1 (2019): 566-572. https://doi.org/10.3892/etm.2019.7654
Copy and paste a formatted citation
x
Spandidos Publications style
Mohamed A, Al-Kafaji G, Almahroos A, Almosawi Z, Alalwan H, Abdulla R, Alammadi F, Almubarak A, Al-Mahrezi A, Kamal A, Kamal A, et al: Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination. Exp Ther Med 18: 566-572, 2019.
APA
Mohamed, A., Al-Kafaji, G., Almahroos, A., Almosawi, Z., Alalwan, H., Abdulla, R. ... Kamal, A. (2019). Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination. Experimental and Therapeutic Medicine, 18, 566-572. https://doi.org/10.3892/etm.2019.7654
MLA
Mohamed, A., Al-Kafaji, G., Almahroos, A., Almosawi, Z., Alalwan, H., Abdulla, R., Alammadi, F., Almubarak, A., Al-Mahrezi, A., Kamal, A."Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination". Experimental and Therapeutic Medicine 18.1 (2019): 566-572.
Chicago
Mohamed, A., Al-Kafaji, G., Almahroos, A., Almosawi, Z., Alalwan, H., Abdulla, R., Alammadi, F., Almubarak, A., Al-Mahrezi, A., Kamal, A."Effects of enhanced environment and induced depression on cuprizone mouse model of demyelination". Experimental and Therapeutic Medicine 18, no. 1 (2019): 566-572. https://doi.org/10.3892/etm.2019.7654
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team